周二，Moderna, Inc. 盘中大涨超12%。公司预计2025年销售额将达到19亿美元，接近此前预测范围的上限，同时将2025年的运营支出预测削减了2亿美元。此外，公司重申了2026年实现高达10%收入增长的目标，并预计今年将获得独立流感疫苗和COVID流感联合疫苗的监管批准。
周二，Moderna, Inc. 盘中大涨超12%。公司预计2025年销售额将达到19亿美元，接近此前预测范围的上限，同时将2025年的运营支出预测削减了2亿美元。此外，公司重申了2026年实现高达10%收入增长的目标，并预计今年将获得独立流感疫苗和COVID流感联合疫苗的监管批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
